Clifford A. Hudis, MD, FACP, on the SOFT Trial
2014 San Antonio Breast Cancer SymposiumClifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract S3-08, “Randomized comparison of adjuvant tamoxifen plus ovarian function suppression vs tamoxifen in premenopausal women with hormone receptor–positive early breast cancer: Analysis of the SOFT trial,” presented by Prudence Francis, MD.
Related Videos
William M. Sikov, MD, on the CALGB 40603 Trial
William M. Sikov, MD, of Women and Infants Hospital, discusses abstract S4-05, ...
Lisa A. Carey, MD, on Pembrolizumab in Advanced Triple-Negative Breast Cancer
Lisa A. Carey, MD, of UNC Lineberger Comprehensive Cancer Center, offers her thoughts on abstract S1-09,
Ann H. Partridge, MD, MPH, of Dana-Farber Cancer Institute, on abstract S3-09, “...
Ann H. Partridge, MD, MPH, on Patient-Reported Outcomes From the SOFT Trial
Lisa A. Carey, MD, on the TNT Trial
Lisa A. Carey, MD, of the UNC Lineberger Comprehensive Cancer Center, discusses abstract S3-01,
Harry D. Bear, MD, PhD, on the NSABP B-51/RTOG 1304 Trial
Harry D. Bear, MD, PhD, of Massey Cancer Center, discusses abstract OT1-3-02, “...
